Response Biomedical Corp – ARRANGEMENT AGREEMENT June 16, 2016 (June 20th, 2016)
Response Biomedical Corp – Response Biomedical Corp. Announces Milestone Achievement in Co-Development Collaboration (February 20th, 2015)
VANCOUVER, B.C., February 16, 2015 - Response Biomedical Corp. ("Response" or "the Company") (TSX: RBM, OTCQB: RPBIF) today announced that it has earned the second milestone of US$720,000 in the funded Technology Development Agreement with Hangzhou Joinstar Biomedical Technology Co. Ltd. ("Joinstar"). The milestone was earned upon the signing of the definitive Collaboration Agreement to support the co-development by Response and Joinstar of components and assays that will run on a high throughput rapid immunoassay analyzer developed by Joinstar. Concurrently, the companies have entered into a definitive Supply Agreement whereby Response will provide certain materials to Joinstar required for Joinstar to manufacture and sell these assays specifically to run on their new analyzer.